肿瘤累及肾上段下腔静脉的手术治疗

Surgical treatment for tumor involved inferior vena cava at the upper segment of kidney

  • 摘要: 目的:探讨肿瘤累及肾上段下腔静脉的手术治疗。
    方法:回顾性分析2007年1月至2015年5月第二军医大学附属长海医院收治的35例累及肾上段下腔静脉肿瘤患者的临床资料。所有患者术前行影像学检查,明确肾上段下腔静脉受累部位和范围。肿瘤类别:肾癌下腔静脉癌栓19例,下腔静脉平滑肌肉瘤5例,下腔静脉平滑肌瘤病3例,肾上腺皮质癌下腔静脉癌栓3例,肝癌下腔静脉癌栓2例,右侧肾上腺嗜铬细胞瘤2例,腹膜后纤维肉瘤下腔静脉癌栓1例。依据肿瘤累及类型,选择不同的手术入路、下腔静脉阻断平面及方法、重建方式、预防癌栓脱落的方法。采用门诊和电话方式进行随访,随访时间截至2015年5月。
    结果:19例肾癌下腔静脉癌栓患者中,10例在术前经颈内静脉放置了下腔静脉滤器;10例行全肝血流阻断,9例行肝下下腔静脉阻断;19例均行肿瘤切除,下腔静脉切开取栓缝合。5例下腔静脉平滑肌肉瘤患者中,3例行全肝血流阻断,2例行肝下下腔静脉阻断;5例患者均切除病变段下腔静脉,其中 4例行人工血管重建,1例合并右肾切除者单纯结扎肿瘤近端和远端下腔静脉和左肾静脉。3例下腔静脉平滑肌瘤病患者中,2例行全肝血流阻断,1例在体外循环下手术;3例患者均行下腔静脉切开取栓缝合,并同时行子宫切除。3例肾上腺皮质癌下腔静脉癌栓患者和2例肝癌下腔静脉癌栓患者均行全肝血流阻断;5例患者中,4例行肿瘤切除联合下腔静脉部分切除直接缝合,1例行下腔静脉部分切除后补片成形。2例右侧肾上腺嗜铬细胞瘤患者术中显露下腔静脉近、远端后悬吊,未阻断;均完整将肿瘤从下腔静脉剥离。 1例腹膜后纤维肉瘤下腔静脉癌栓患者,拟行肝下下腔静脉阻断,但术中发生癌栓脱落肺栓塞,患者死亡。35例患者中,34例顺利完成手术,1例围术期死亡。34例患者平均手术时间为2.8 h(1.5~5.0 h),平均术中出血量为2 000 mL(400~5 000 mL)。34例患者围术期无严重并发症发生。34例患者术后平均住院时间为9.2 d(6.0~16.0 d)。34例患者术后获得随访,中位随访时间为12个月(1~60个月)。随访期间, 1例下腔静脉平滑肌肉瘤和2例肾上腺皮质癌患者肿瘤复发死亡,1例肝癌患者肿瘤复发,其余患者无瘤生存。
    结论:肿瘤累及肾上段下腔静脉并非手术切除的禁忌证。根据肿瘤累及下腔静脉的范围和方式,选择合适的显露途径、阻断平面及血管重建方法,可安全切除肿瘤。

     

    Abstract: Objective:To investigate surgical treatment for tumor involved inferior vena cava at the upper segment of kidney.
    Methods:The clinical data of 35 patients with tumor involved inferior vena cava at the upper segment of kidney who were admitted to Changhai Hospital affiliated to the Second Military Medical University from January 2007 to May 2015 were retrospectively analyzed. All the patients received preoperative imaging examinations to insure the site and range of inferior vena cava involvement at the upper segment of kidney. Renal cell carcinomas with inferior vena cava involvement were found in 19 cases, leiomyosarcomas of inferior vena cava in 5 cases, leiomyomatosis involving inferior vena cava in 3 cases, adrenocortical carcinoma involving inferior vena cava in 3 cases, liver cancer involving inferior vena cava in 2 cases, right adrenal pheochromocytomas in 2 cases, retroperitoneal fibrosarcoma involving inferior vena cava in 1 case. According to tumor involvement types, the different surgical approaches, planes and method of inferior vena cava exclusion, reconstruction method and prevention of tumor embolus detachment were selected. Patients were followed up by outpatient examination and telephone interview till May 2015.
    Results:Among 19 patients with renal cell carcinomas with inferior vena cava involvement, 10 patients were placed inferior vena cava filters through internal jugular vein before surgery, 10 patients underwent total hepatic vascular exclusion and 9 patients underwent intrahepatic inferior vena cava exclusion. All the 19 patients received tumor resection and inferior vena cava embolectomy.
    Of the 5 patients with leiomyosarcomas of inferior vena cava, 3 patients underwent total hepatic vascular exclusion and 2 patients underwent intrahepatic inferior vena cava exclusion. The diseased segments of 5 patients were resected, including 4 patients of artificial vascular graft and 1 patient complicated with resection of right kidney receiving simple ligation of inferior vena cava and left renal vein at proximal and distal tumors. Of the 3 patients with leiomyomatosis involving inferior vena cava, 2 patients received total hepatic vascular exclusion and 1 was treated surgically under cardiopulmonary bypass. All the 3 patients underwent inferior vena cava embolectomy and hysterectomy. Three patients with adrenocortical carcinoma involving inferior vena cava and 2 patients with liver cancer involving inferior vena cava underwent total hepatic vascular exclusion. Among the 5 patients, 4 had direct suture after tumor removal combined with partial inferior vena cava resection, and 1 had patch repair after partial inferior vena cava resection. Two patients with right adrenal pheochromocytomas were exposed proximal and distal lifting devices of inferior vena cava without clamp, and the tumors were peeled off completely. Intraoperative death happened in the patient with retroperitoneal fibrosarcoma involving inferior vena cava who was prepared to undergo intrahepatic inferior vena cava exclusion but encountered intraoperative pulmonary embolism due to tumor thrombus shedding. Thirtyfour patients of 35 patients underwent operation successfully without serious perioperative complications and a patient died in the perioperative period. The mean operation time, volume of intraoperative blood loss and duration of postoperative hospital stay were 2.8 hours (range, 1.5-5.0 hours), 2 000 mL (range, 400- 5 000 mL) and 9.2 days (range, 6.0-16.0 days). Thirtyfour patients were followed up for a median time of 12 months (range, 1-60 months). During the followup period, a patient with leiomyosarcomas of inferior vena cava and 2 patients with adrenocortical carcinoma involving inferior vena cava died of tumor recurrence, a patient with liver cancer had tumor recurrence, other patients were tumorfree survival.
    Conclusions:Inferior vena cava at the upper segment of kidney is not contraindication for tumor resection. The appropriate way to expose, clamp and reconstruct are selected to safely remove the tumor based on extension and method of tumor involving inferior vena cava.

     

/

返回文章
返回